Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease

Molecular Biology Reports

Volumn 40, Issue 4, 2013, Pages 3065-3071

  Abdel Aziz, T A ^a   Mohamed, R H ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

eNOS; Genetic polymorphism; Premature CAD

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; DYSLIPIDEMIA; EGYPT; ENOS GENE; FEMALE; GENE; GENE ACTIVITY; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL; CORONARY ARTERY DISEASE; EGYPT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRIGLYCERIDES;

EID: 84878405820     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2380-7     Document Type: Article

References (38)

1. Isordia-Salas I, Leaños-Miranda A, Borrayo-Sánchez G (2010) The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 411:553-557
2. Szolnoki Z (2009) Evaluation of common unfavourable genetic variants in cerebrovascular diseases: recommendation for supportive genetic examinations and methodological approaches for common genetic variants. Curr Med Chem 16:3168-3173
3. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478-17488
4. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
5. Wang XL, Wang J (2000) Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 70:241-251
6. Hingorani AD (2003) Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 5:19-25
7. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S (1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 32:521-526
8. Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and heart disease. Meta-analysis of 26 studies involving 23038 subjects. Circulation 109:1359-1365
9. Cam SF, Sekuri C, Tengiz I, Ercan E, Sagcan A, Akinm M, Berdeli A (2005) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Throm Res 116:287-292
10. Abd El-Aziz TA, Hussein YM, Mohamed RH, Shalaby SM (2012) Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease. Gene 498:270-275
11. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486 -2497
12. Frieldewald WT, Levy RS, Fridricken DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1:499-502
13. Assman SF, Hosmer DW, Lemeshow S, Mundt KA (1996) Confidence intervals for measures of interaction. Epidemiology 7:286-290
14. Roncaglioni MC, Santoro L, D'Avanzo B, Negri E, Nobili A, Ledda A, Pietropaolo F, Franzosi MG, LaVecchia C, Feruglio GA, Maseri A (1992) Role of family history in patients with myocardial infarction: an Italian case-control study. GISSIEFRIM Investigators. Circulation 85:2065-2072
15. Berdeli A, Sekuri C, Cam FS, Ercan E, Sagcan A, Tengiz I, Eser E, AkIn M (2005) Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 351:87-94
16. Gardemann A, Lohre J, Cayci S, Katz N, Tillmanns H, Haberbosch W (2002) The T allele of the missense Glu298Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 160:167-175
17. Aras O, Hanson NQ, Bakanay SM, Tsai MY, Gulec S (2002) Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost 87:347-349
18. Nassar BA, Bevin LD, Johnstone DE, O'Neill BJ, Bata IR, Kirkland SA, Title LM (2001) Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J 142(4):586-589
19. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikäheimo M, Päivänsalo M, Savolainen MJ, Kesäniemi YA (2002) Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251(2):102-110
20. Guo X, Cheng S, Taylor KD, Cui J, Hughes R, Quinones MJ, Bulnes-Enriquez I, De la Rosa R, Aurea G, Yang H, Hsueh W, Rotter JI (2005) Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 45:799-803
21. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506-1510
22. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K (2000) Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T786C and missense Glu298Asp variants. J Investig Med 48:367-374
23. 298 → Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87:525-528
24. Antoniades C, Tousoulis D, Vasiliadou C, Pitsavos C, Chrysochoou C, Panagiotakos D, Tentolouris C, Marinou K, Koumallos N, Stefanadis C (2005) Genetic polymorphism on endothelial nitric oxide synthase affects endothelialn activation and inflammatory response during the acute phase of myocardial infarction. J Am Coll Cardiol 46:1101-1109
25. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L (1999) Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29:284-290
26. Wang CL, Hsu LA, Ko YS, Ko YL, Lee YH (2001) Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Form Med Assoc 100:736-740
27. Granath B, Taylor RR, van Bockxmeer FM, Mamotte CD (2001) Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 8:235-241
28. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916-1923
29. Fricker R, Hesse C, Weiss J, Tayrouz Y, Hoffmann MM, Unnebrink K, Mansmann U, Haefeli WE (2004) Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradation. Br J Clin Pharmacol 58:169-177
30. Rossi GP, Taddei S, Virdis A, Cavallin M, Ghiadoni L, Favilla S, Versari D, Sudano I, Pessina AC, Salvetti A (2003) The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 41:938-945
31. Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG (2004) Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298 → Asp and T-786 → C polymorphisms. Stroke 35(6):1305-1309
32. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ (1999) A common variant of the endothelial nitric oxide synthase (Glu298-Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520
33. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
34. De Caterina R (2000) Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Lipidol 11:9-23
35. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G, Piatti P (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52(5):1270-1275
36. Hayden MR, Tyagi SC (2003) Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stres. Cardiovasc Diabetol. 2:2
37. Bayoglu B, Ersoz M, Cagatay P, Ciftci C, Duman BS (2008) Lack of association between endothelial nitric oxide synthase Glu298Asp variation, visceral obesity and insulin related phenotypes in Turkish type 2 diabetic patients. Acta Medica Academica 37:91-98
38. Ukkola O, Erkkila PH, Savolainen MJ, Kesaniemi YA (2001) Lack of association between polymorphism of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Int Med. 249(5):451-459